Patents by Inventor Adrian Merlo

Adrian Merlo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING CANCER BY MODULATING MNK
    Publication number: 20110280886
    Abstract: The present invention relates to a method for treating cancer in a subject using a mTOR inhibitor in combination with a therapeutically effective amount of a modulator of a MNK.
    Type: Application
    Filed: November 11, 2009
    Publication date: November 17, 2011
    Applicants: UNIVERSITY HOSPITAL BASEL, NOVARTIS FORSCHUNGSSTIFTUNG, ZWEIGNIEDERLASSUNG, F RIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEAR
    Inventors: Michal Grzmil, Brian Arthur Hemmings, Adrian Merlo, Pier Jr Morin
  • Radiopharmaceuticals for cancer diagnosis and treatment
    Publication number: 20070053837
    Abstract: Radionuclide labelled conjugates based on substance P and analogues thereof with the chelator (DOTAGA) (1-(1-rarboxy-3-carboxy-propyl)-4,7,10(carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane, DOTASA (1-(1-carboxy-2carboxy-ethyl)-4,7,10(carboxymethyl)1,4,7,10-tetraazacyclo-dodecane, or chelator (DOTA) [1,4,7,10 tetraazaacyclo-dodecane 1,4,7,10-tetra(acetic acid)] are useful radiopharmaceutical substances for targeting and treatment of brain tumors, especially gliomas.
    Type: Application
    Filed: March 18, 2004
    Publication date: March 8, 2007
    Applicants: Kantonsspital Basel, Universitat Bern
    Inventors: Adrian Merlo, Helmut Macke, Jean-Claude Reubi, Stephan Good